Microbial signatures in the lower airways of mechanically ventilated COVID19 patients associated with poor clinical outcome
暂无分享,去创建一个
J. Clemente | C. Forst | A. Heguy | T. Uyeki | A. Koide | S. Koide | E. Ghedin | G. Jour | A. Schmidt | D. Sterman | J. Bakker | K. Khanna | E. de Wit | Y. Li | Huilin Li | Chan Wang | L. Segal | X. Liu | L. Pérez-Pérez | B. Shopsin | V. Mukherjee | C. Wang | M. Weiden | N. Amoroso | S. Brosnahan | L. Desvignes | A. Labarbiera | B. Zhang | R. Duerr | P. Meyn | D. Pradhan | H. Li | Yonghua Li | L. Angel | S. Yeung | G. Shen | D. Kaufman | S. Rafeq | A. Lubinsky | K. Ji | Xiuxiu Liu | D. Pradhan | M. Chung | I. Sulaiman | J. Clemente | R. Postelnicu | J. Bakker | J. Tsay | S. Thannickal | S. Banakis | Bin Zhang | C. Barnett | K. Krolikowski | R. Schluger | J. Carpenito | Chang Wang | J. Tsay | Laura E. Evans | L. Angel | L. Evans | D. Collazo | B. Wu | Jun-Chieh J. Tsay | Kenneth A. Stapleford | Benjamin G. Wu | Timothy M. Uyeki | Sara A. Thannickal | Adriana Hegu
[1] H. Feldmann,et al. Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys , 2021, Science Translational Medicine.
[2] Cameron R. Wolfe,et al. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 , 2020, The New England journal of medicine.
[3] C. Rice,et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA , 2020, Science Translational Medicine.
[4] A. Belot,et al. Protracted viral shedding and viral load are associated with ICU mortality in Covid-19 patients with acute respiratory failure , 2020, Annals of Intensive Care.
[5] Richard Bonneau,et al. Lower airway dysbiosis affects lung cancer progression. , 2020, Cancer discovery.
[6] Mingan Yang,et al. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia‐reperfusion , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] G. Millet,et al. Mitochondria – in the crossfire of SARS-CoV-2 and immunity , 2020, iScience.
[8] Steven M. Holland,et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.
[9] Jacques Fellay,et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.
[10] Yangyang Xia,et al. Nrf2 and STAT3 Alleviates Ferroptosis-Mediated IIR-ALI by Regulating SLC7A11 , 2020, Oxidative medicine and cellular longevity.
[11] M. Loda,et al. SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19 , 2020, Cancer Cell.
[12] Lianfeng Zhang,et al. LncRNA Malat1 inhibition of TDP43 cleavage suppresses IRF3-initiated antiviral innate immunity , 2020, Proceedings of the National Academy of Sciences.
[13] S. Hadjadj,et al. Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study , 2020, Diabetes Care.
[14] S. Zolla-Pazner,et al. Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 , 2020, medRxiv.
[15] Mina T. Kelleni. SARS CoV-2 viral load might not be the right predictor of COVID-19 mortality , 2020, Journal of Infection.
[16] S. Hadjadj,et al. Relationship between obesity and severe COVID‐19 outcomes in patients with type 2 diabetes: Results from the CORONADO study , 2020, Diabetes, obesity & metabolism.
[17] P. Benos,et al. Respiratory Tract Dysbiosis is Associated With Worse Outcomes in Mechanically-Ventilated Patients. , 2020, American journal of respiratory and critical care medicine.
[18] D. MacFadden,et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis , 2020, Clinical Microbiology and Infection.
[19] Michael D Healy,et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality , 2020, Nature Communications.
[20] L. Argaud,et al. Early bacterial co-infection in ARDS related to COVID-19 , 2020, Intensive Care Medicine.
[21] Yangyang Xia,et al. Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1 , 2020, Aging.
[22] Morten Nielsen,et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 , 2020, Cell.
[23] S. Ng,et al. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge , 2020, Gastroenterology.
[24] Fayzan F. Chaudhry,et al. SARS-CoV-2 viral load predicts COVID-19 mortality , 2020, The Lancet Respiratory Medicine.
[25] O. Schwartz,et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2 , 2020, Science Translational Medicine.
[26] D. Brodie,et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, The Lancet.
[27] M. Brenner,et al. Tracheostomy in the COVID-19 era: global and multidisciplinary guidance , 2020, The Lancet Respiratory Medicine.
[28] I. Amit,et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 , 2020, Nature Medicine.
[29] B. Zhu,et al. Co-infection with respiratory pathogens among COVID-2019 cases , 2020, Virus Research.
[30] L. Westblade,et al. Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City , 2020, Journal of Clinical Microbiology.
[31] Jie Dong,et al. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients , 2020, Cell Host & Microbe.
[32] W. Lim,et al. Co-infections in people with COVID-19: a systematic review and meta-analysis , 2020, Journal of Infection.
[33] M. Hallek,et al. COVID‐19 associated pulmonary aspergillosis , 2020, Mycoses.
[34] K. Fung,et al. Recommendations from the CSO-HNS taskforce on performance of tracheotomy during the COVID-19 pandemic , 2020, Journal of Otolaryngology - Head & Neck Surgery.
[35] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[36] N. Shah,et al. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. , 2020, JAMA.
[37] Xuetao Cao. COVID-19: immunopathology and its implications for therapy , 2020, Nature Reviews Immunology.
[38] S. Merler,et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.
[39] P. Vollmar,et al. Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.
[40] D. Spain,et al. Performing tracheostomy during the Covid-19 pandemic: guidance and recommendations from the Critical Care and Acute Care Surgery Committees of the American Association for the Surgery of Trauma , 2020, Trauma Surgery & Acute Care Open.
[41] D. Chhetri,et al. Tracheostomy Considerations during the COVID-19 Pandemic , 2020, OTO open.
[42] T. West,et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series , 2020, The New England journal of medicine.
[43] Sharukh Lokhandwala,et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. , 2020, JAMA.
[44] Hyeshik Chang,et al. The Architecture of SARS-CoV-2 Transcriptome , 2020, Cell.
[45] MingKun Li,et al. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] MingKun Li,et al. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[47] Ting Yu,et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.
[48] T. Lancet. Emerging understandings of 2019-nCoV , 2020, The Lancet.
[49] T. van der Poll,et al. Lung Microbiota Predict Clinical Outcomes in Critically Ill Patients. , 2020, American journal of respiratory and critical care medicine.
[50] Hui-chao Yan,et al. Wnt/β‐catenin‐mediated heat exposure inhibits intestinal epithelial cell proliferation and stem cell expansion through endoplasmic reticulum stress , 2020, Journal of cellular physiology.
[51] Bo Zhong,et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak , 2020, Emerging microbes & infections.
[52] Wenhong Zhang,et al. Risks and features of secondary infections in severe and critical ill COVID-19 patients , 2020, Emerging microbes & infections.
[53] D. Figeys,et al. Advancing functional and translational microbiome research using meta-omics approaches , 2019, Microbiome.
[54] E. Ghaemi,et al. Genomic analyses of a novel bacteriophage (VB_PmiS-Isfahan) within Siphoviridae family infecting Proteus mirabilis. , 2019, Genomics.
[55] Jennifer Lu,et al. Improved metagenomic analysis with Kraken 2 , 2019, Genome Biology.
[56] A. Prévost-Blondel,et al. The IL4I1 Enzyme: A New Player in the Immunosuppressive Tumor Microenvironment , 2019, Cells.
[57] Ash A. Alizadeh,et al. Determining cell-type abundance and expression from bulk tissues with digital cytometry , 2019, Nature Biotechnology.
[58] I. Bahar,et al. Iron catalysis of lipid peroxidation in ferroptosis: Regulated enzymatic or random free radical reaction? , 2019, Free radical biology & medicine.
[59] Richard Bonneau,et al. Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer , 2018, American journal of respiratory and critical care medicine.
[60] Simon C Watkins,et al. Pseudomonas aeruginosa utilizes host polyunsaturated phosphatidylethanolamines to trigger theft-ferroptosis in bronchial epithelium , 2018, The Journal of clinical investigation.
[61] E. Wiertz,et al. The influence of TAP1 and TAP2 gene polymorphisms on TAP function and its inhibition by viral immune evasion proteins , 2018, Molecular immunology.
[62] J. Clemente,et al. Evaluation of the airway microbiome in nontuberculous mycobacteria disease , 2018, European Respiratory Journal.
[63] Joshua D. Campbell,et al. Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection , 2017, Cancer Prevention Research.
[64] A. Butte,et al. xCell: digitally portraying the tissue cellular heterogeneity landscape , 2017, bioRxiv.
[65] Rob Patro,et al. Salmon provides fast and bias-aware quantification of transcript expression , 2017, Nature Methods.
[66] Xiaowei Zhan,et al. FMAP: Functional Mapping and Analysis Pipeline for metagenomics and metatranscriptomics studies , 2016, BMC Bioinformatics.
[67] Benjamin H Singer,et al. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome , 2016, Nature Microbiology.
[68] Bjoern Peters,et al. Transcriptional Profiling of Th2 Cells Identifies Pathogenic Features Associated with Asthma , 2016, The Journal of Immunology.
[69] T. Walsh,et al. Low-pathogenicity Mycoplasma spp. alter human monocyte and macrophage function and are highly prevalent among patients with ventilator-acquired pneumonia , 2016, Thorax.
[70] P. Cohen,et al. The Mitochondrial-Derived Peptide Humanin Protects RPE Cells From Oxidative Stress, Senescence, and Mitochondrial Dysfunction , 2016, Investigative ophthalmology & visual science.
[71] Bin Zhang,et al. Multiscale Embedded Gene Co-expression Network Analysis , 2015, PLoS Comput. Biol..
[72] I. Cristea,et al. Intricate Roles of Mammalian Sirtuins in Defense against Viral Pathogens , 2015, Journal of Virology.
[73] Chao Xie,et al. Fast and sensitive protein alignment using DIAMOND , 2014, Nature Methods.
[74] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[75] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[76] Charity W. Law,et al. voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.
[77] M. Lameiras,et al. A comparative overview , 2013 .
[78] S. Uhlig,et al. Inositol-trisphosphate reduces alveolar apoptosis and pulmonary edema in neonatal lung injury. , 2012, American journal of respiratory cell and molecular biology.
[79] Hélène Touzet,et al. SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data , 2012, Bioinform..
[80] M. Kanehisa,et al. Using the KEGG Database Resource , 2005, Current protocols in bioinformatics.
[81] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[82] C. Quince,et al. Dirichlet Multinomial Mixtures: Generative Models for Microbial Metagenomics , 2012, PloS one.
[83] Michael Mitzenmacher,et al. Detecting Novel Associations in Large Data Sets , 2011, Science.
[84] Susumu Goto,et al. KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..
[85] R. Knight,et al. UniFrac: an effective distance metric for microbial community comparison , 2011, The ISME Journal.
[86] Kuender D Yang,et al. Correlation of Pandemic (H1N1) 2009 Viral Load with Disease Severity and Prolonged Viral Shedding in Children , 2010, Emerging infectious diseases.
[87] J. Sung,et al. Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza , 2009, The Journal of infectious diseases.
[88] Marcel H. Schulz,et al. A Global View of Gene Activity and Alternative Splicing by Deep Sequencing of the Human Transcriptome , 2008, Science.
[89] B. Williams,et al. Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.
[90] I. Goodhead,et al. Dynamic repertoire of a eukaryotic transcriptome surveyed at single-nucleotide resolution , 2008, Nature.
[91] Anne-Béatrice Dufour,et al. The ade4 Package: Implementing the Duality Diagram for Ecologists , 2007 .
[92] Anthony S Fauci,et al. The 1918 influenza pandemic: insights for the 21st century. , 2007, The Journal of infectious diseases.
[93] M. Katze,et al. Integrated Molecular Signature of Disease: Analysis of Influenza Virus-Infected Macaques through Functional Genomics and Proteomics , 2006, Journal of Virology.
[94] L. Poon,et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .
[95] T. Regad,et al. Role and fate of PML nuclear bodies in response to interferon and viral infections , 2001, Oncogene.
[96] K. Hoppu,et al. Inositol supplementation in premature infants with respiratory distress syndrome. , 1992, The New England journal of medicine.
[97] Alfonso J. Rodriguez-Morales,et al. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview , 2020 .
[98] Monther Alhamdoosh,et al. RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR , 2016, F1000Research.
[99] V. Preedy,et al. Prospective Cohort Study , 2010 .
[100] J. Manson,et al. Prospective Study of , 2007 .